Alopecia News

One in eight women will suffer from breast cancer in their lifetime. Eight percent will decline treatment due to the fear of alopecia.

SARS-CoV-2 infection, especially a severe case or without vaccination, significantly increases the long-term risk for developing autoimmune and autoinflammatory connective tissue diseases, according to data published in JAMA Dermatology.

Major strides have been made in alopecia research in 2024. The FDA’s approval of the oral Janus kinase inhibitor Leqselvi was the most-read alopecia article on Healio this year, with studies about minoxidil and metformin also making the list.

Patients with hair loss disorders often suffer severe mental health effects. While medical intervention has grown in recent years, many individuals still rely on cranial hair prostheses, or wigs, which can be costly.

A combination of topical finasteride and minoxidil was more efficacious than minoxidil alone in the treatment of male pattern androgenic alopecia, according to a study.

Beneath the Surface is a video series in which Joel M. Gelfand, MD, MSCE, Healio cDermatology Chief Medical Editor, discusses hot topics in the field with leading experts.

An in-depth interview about the effects of the CMS’s 2025 physician fee schedule on patient access topped Healio Dermatology’s most-read articles of November, with FDA news also garnering attention.

ORLANDO — In this Healio video exclusive, Jeanine Downie, MD, FAAD, discussed the Unplugged session from the American Society for Dermatologic Surgery Annual Meeting.

Low-dose oral minoxidil was not significantly associated with pericardial effusion among patients with alopecia, according to a study.